Intervertebral disc nucleus pulposus extracellular matrix (NP ECM)

The intervertebral disc nucleus pulposus extracellular matrix (NP ECM) is a specialized, highly hydrated gelatinous structure located at the center of the intervertebral disc, primarily composed of type II collagen and the proteoglycan aggrecan (Roughley, 2004, PMID: 15534593). Its high water content, maintained by the osmotic pressure of glycosaminoglycans, allows the disc to resist compressive forces and provide flexibility to the spine (Vergroesen et al., 2015, PMID: 25894427). In intervertebral disc degeneration (IDD), the NP ECM undergoes biochemical shifts, including a loss of aggrecan and a transition from type II to type I collagen, leading to dehydration and structural failure (Adams & Roughley, 2006, PMID: 16908000). Therapeutic strategies targeting the NP ECM include chemonucleolysis using enzymes like chymopapain to treat herniation by degrading the matrix (Kim et al., 2003, PMID: 12743231) and regenerative approaches using growth factors like GDF-5 or Link N peptide to stimulate matrix synthesis (Masuda, 2008, PMID: 18404002). Understanding the NP ECM is crucial for developing treatments for chronic low back pain and spinal disorders.

Other names

Nucleus pulposus matrixNP extracellular matrixIntervertebral disc matrixNucleus pulposus ECM

Therapeutic interventions target the NP ECM through enzymatic degradation (chemonucleolysis) to reduce the volume of herniated tissue and relieve nerve pressure, or through the delivery of anabolic growth factors and biological scaffolds to stimulate the synthesis of collagen type II and aggrecan, thereby restoring disc height and hydration (Masuda, 2008, PMID: 18404002; Kim et al., 2003, PMID: 12743231).